Search

Search Constraints

You searched for: Author/Creator Mehta, Amitkumar

Search Results

1. Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study. Issue 7 (July 2019)

7. Diffuse large B‐cell lymphoma with primary treatment failure: Ultra‐high risk features and benchmarking for experimental therapies. Issue 2 (February 2017)

8. Phase 2 study of parsaclisib (INCB050465), a highly selective, next-generation PI3Kδ inhibitor, in relapsed or refractory diffuse large B-cell lymphoma (CITADEL-202). Issue 2 (28th January 2021)

9. A nomogram including baseline prognostic factors to estimate the activity of second‐line therapy for advanced urothelial carcinoma. (May 2014)